Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Brain : a Journal of Neurology|September 1, 1999
Left frontal transcranial magnetic stimulation reduces contralesional extinction in patients with unilateral right brain damageM Oliveri, P M Rossini, R Traversa, et al.
Brain : a Journal of Neurology|September 1, 1999
Interhemispheric asymmetries in the perception of unimanual and bimanual cutaneous stimuli. A study using transcranial magnetic stimulationM Oliveri, P M Rossini, P Pasqualetti, et al.
Neuroreport|April 11, 2000
Transcranial magnetic stimulation reveals an interhemispheric asymmetry of cortical inhibition in focal epilepsyP Cicinelli, D Mattia, F Spanedda, et al.
Brain : a Journal of Neurology|August 26, 2000
Time-dependent activation of parieto-frontal networks for directing attention to tactile space. A study with paired transcranial magnetic stimulation pulses in right-brain-damaged patients with extinctionM Oliveri, P M Rossini, M M Filippi, et al.
Neurology|July 11, 2001
Effects of motor imagery on motor cortical output topography in Parkinson's diseaseM M Filippi, M Oliveri, P Pasqualetti, et al.
Neuroscience Letters|January 2, 1991
Neuromagnetic somatosensory homunculus: a non-invasive approach in humansL Narici, I Modena, R J Opsomer, et al.
Experimental Brain Research|March 1, 2003
Influence of the supplementary motor area on primary motor cortex excitability during movements triggered by neutral or emotionally unpleasant visual cuesM Oliveri, C Babiloni, M M Filippi, et al.
Neuroreport|July 23, 1998
Hand motor cortical area reorganization in stroke: a study with fMRI, MEG and TCS mapsP M Rossini, C Caltagirone, A Castriota-Scanderbeg, et al.
Rivista Di Neurologia|January 1, 1987
Non-clinical tests for the diagnosis of multiple sclerosisP M Rossini, M Caramia, F Lavaroni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2012
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugsH Tedeholm, J Lycke, B Skoog, et al.
Pageof 9